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ABSTRACT

The effect of parenteral administration of vitamin E during the pregnancy and
lactation period of ewes and their lambs on innate and humoral components of the
immune system was investigated in a 3 part study.

1.) Pregnant/Lactating ewes:

Fifteen pregnant Dorset sheep were supplemented with vitamin E (30 IU d-atocopherol /Kg body weight (BW), E, n=lO) or placebo (emulsified base, P, n=5) from
the last trimester of gestation through weaning. Blood and colostrum were analyzed
every 2 wk for a-tocopherol, selenium, glutathione peroxidase activity, lysozyme
activity, total lgG and IgG antibodies against tetanus toxoid. 2.) Lambs (0-8wks):
Lambs born to E and P supplemented ewes received either vitamin E (30 IU d-atocopherol /Kg BW) or placebo (emulsified base) every 2 weeks from birth through 8
wk of age. This resulted in four treatment groups: E/E (n=lO), E/P (n=l 1), PIE (n=4),

PIP (n=5). The lambs were sampled every other week and their blood was analyzed as
for the ewes. 3.) Lambs (Vaccination period): When the youngest lamb reached 8
wks of age all lambs were vaccinated as a group against Clostridium perfringens and
Clostridium tetani. Booster

va~cinations

were given 4 wk later. Blood was sampled

prior to primary vaccination, 1 wk post vaccination and then every 2 wk until 7 wk
post vaccination. Results: Pregnant/Lactating ewes: Serum vitamin E concentrations
increased over time in supplemented ewes as compared to placebo ewes. Colostrum
vitamin E levels were also increased in supplemented versus placebo ewes. Vitamin E
supplementation did not influence plasma selenium, glutathione peroxidase activity
and serum lysozyme, IgG and IgG against tetanus toxoid in the serum or colostrum of
ewes. There were fluctuations within treatment in the production of IgG in response

to parturition. Lambs (0-8wks):

Lambs directly supplemented with vitamin E in

addition to maternal supplementation (E/E) had higher levels of serum a-tocopherol
than the placebo group (PIP).

There were no differences in plasma selenium,

glutathione peroxidase activity, serum lysozyme, IgG and IgG against tetanus toxoid
concentrations between groups. There was a loss of maternal antibodies over time in
all lambs.

Serum lysozyme activity was higher at birth, prior to ingestion of

colostrum, in lambs that received maternal vitamin E supplementation compared to the
lambs that received only direct vitamin E supplementation.

Lambs (Vaccination

period): Serum a-tocopherol levels increased in lambs that received direct vitamin E
supplementation (E/E and PIE) irrespective of maternal supplementation (PIP and
EIP). Plasma selenium, glutathione peroxidase activity, serum lysozyme and IgG did
not differ between treatment groups. There was an increase in the production of IgG
against tetanus toxoid in response to booster vaccination in PE lambs. Conclusions:
Supplemental vitamin E to the ewes and lambs, at 30 IU/Kg BW, had a modest effect
on parameters used in this study to assess innate and humoral immunity.
(Key words: vitamin E, ewe, IgG, tetanus toxoid)
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PREFACE

This thesis is written in a manuscript format. Chapter 1 includes detailed information
on current vitamin E research. A condensed paper about the study is presented in
chapter 2. Additional details on methods used throughout the study are presented in
the appendices.
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CHAPTER I:
Review of Literature
INTRODUCTION

The immune system protects the host from invading microorganisms through
complex pathways of recognition and elimination. Disease occurs when the immune
system is compromised by infectious pathogens. Humans and animals are susceptible
to infections throughout their lives, but are more susceptible when undergoing
physiological stress, malnourishment or at varying stages of life such as birth,
gestation and lactation. Infections are the major cause of production losses and can
affect animals of all ages. The nutritional status of an animal can influence host
resistance and susceptibility to disease (Hidiroglou, et al., 1992). Effects of nutrition
on disease resistance have long been recognized and the knowledge is being applied to
farm animal production systems and particularly to ruminants. Nutritional
supplementation to improve host immunity has always been an area of interest to
researchers and is the subject of this thesis.
There are 5.7 million sheep and lambs in United States (USDA, 2008). These
sheep are used for their meat, wool, milk, hide, and other by products. Losses to the
sheep industry from nonpredator causes account for $33 million annually (USDA,
2005) with the majority of these losses attributed to infections.

About 15-50%

mortality is seen before weaning, with the most of the mortality occurring in first 24
hrs of life (Bekele, et al., 1992, Rowland, et al., 1992). This increased susceptibility
can be attributed to immature immune system of the neonates.

Supplementation with vitamin E has been shown to modulate immune function
in humans (Meydani, et al., 1990) and several species of animals including ruminants

(Afzal, et al., 1984, Beharka, et al., 1997, Ellis and Vorhies, 1976, Moriguchi and
Muraga, 2000, Reddy, et al., 1987, Ritacco, et al., 1986, Segagni, 1955, Tengerdy,
1989). Although vitamin E has been investigated extensively, little research has been
undertaken to establish whether supplementation of vitamin E to small ruminants
during gestation, lactation and early in life has a beneficial impact on immune function
in these animals.
Innate Immunity

In general, the immune system can be broadly categorized into two divisions:
innate and adaptive. The cells of the innate immune system serve as the first line of
defense and act nonspecifically towards antigens. The innate response is mediated
through antimicrobial molecules such as lysozyme, lactoferrin, nitric oxide, and the
various cells of defense i.e. natural killer cells, macrophages, neutrophils, and mast
cells.
Lysozyme is a hydrolytic enzyme present in serum, tears, seminal fluid, milk,
and in phagocytic cells. It has bactericidal effect on most gram-positive and some
gram-negative bacteria and viruses.

It binds to the surface of the susceptible

pathogens and promotes their lysis (Tizard, 2000).
Glutathione peroxidase (GSH-Px) is an enzymatic antioxidant that belongs to
the selenoprotein family and catalyzes the reduction of hydrogen and lipid peroxides
to their corresponding alcohols (Loscalzo, 2008). It plays a key role in maintaining
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the physiological balance between prooxidants and antioxidants (Zablocka and Janusz,
2008).
Adaptive Immunity

The adaptive immune response constitutes humoral and cell mediated
immunities that use B and T lymphocytes respectively to neutralize pathogens in an
antigen specific manner. Humoral immunity is mediated through antibodies whereas
cell mediated immunity is mediated through cytokines, namely interleukins and
interferons, that act as chemical messengers (Tizard, 2000).

B-lymphocytes that

mature in bone marrow provide humoral immunity through antibodies - IgG, IgM,
IgA, IgD, and IgE. Antibodies bind to specific antigens and enhance their destruction
and elimination. Blood contains high levels of IgG followed by IgM and then IgA. T
lymphocytes mature in thymus and are divided into T helper and T cytotoxic cells to
lyse extracellular and intracellular organisms.

Cytokines produced by the cellular

immune system act as chemical messengers further activating Band T lymphocytes as
well as other immune cells such as natural killer cells and macrophages (Tizard,
2000).
Maternal immune system

The maternal immune system during the transition period, which includes
pregnancy, parturition, and lactation, is under extreme stress.

The stress during

pregnancy and increased metabolic demands during parturition and lactation result in
increased production of reactive oxygen species leading to oxidative stress (Spears and
Weiss, 2008). In addition to these drains on the animal's physical resources, they
must be in a suitable physiological state to ensure repair of any tissue damaged during
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parturition, and to maintain resistance to infections (Andrieu, 2008).

This

physiological stress can have a negative impact on neutrophil function, antibody
responses, and cytokine production by immune cells (Spears and Weiss, 2008). The
compromised immune system of the dam not only influences their own immune
function but can also affect their offspring.

Neonatal immune system
Neonates have an immature immune system that renders them susceptible to a
wide variety of bacterial and viral pathogens. They have impaired immune responses
due to a range of deficiencies in both adaptive and innate immunity. Additionally,
maternal antibodies transferred with colostrum activate and regulate innate responses
present in the neonate to fight against infection, but at the same time can interfere with
the neonates ability to develop specific immunity against various antigens (Chase, et
al., 2008). The interaction of the maternal and neonatal immune system is depicted in
Fig. I. Immunity is low at birth and a peak in passive immunity occurs after ingestion
of colostrum. Passive immunity offers protection to the newborn through maternal
antibodies. Active immunity, which has to be developed by the newborn, is low at
birth and gradually increases with age. When passive immunity starts to wane and
active immunity is not fully established to confer sufficient protection there is a
window of susceptibility to infections (Chase, et al., 2008).
Infections are a major cause of neonatal losses.
infections either from the environment or from the dam.

Newborns can acqmre
Additionally, maternal

honnones produced prior to parturition can lead to immunosuppression in the
offspring (Jacob, et al., 2001). Overall, these infections, coupled with a naYve immune
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system, leads to significant losses either from mortality or decreased production
efficiency. To protect newborns from infectious pathogens and increase their disease
resistance, the immune function of the dam, newborn or both needs to be enhanced.
As the epitheliochorial placenta of ruminants does not allow passage of
immunoglobulins from dam to fetus, colostrum is the only efficient source of immune
components and nutrients

to

the

neonate.

Colostrum contains proteins,

immunoglobulins, nonprotein nitrogen, fat, vitamins and minerals. Hence, improving
the dam's immune system may increase immunoglobulin transfer to the newborns
through the colostrum. Boosting the newborns own immune system will increase their
resistance to infections. Any measures that can be shown to improve host resistance to
infections will have a major impact in reducing morbidity, mortality, and improving
production efficiency.
REACTIVE OXYGEN SPECIES AND ANTIOXIDANTS

The maternal immune system during gestation and lactation and neonatal
immune system is under extreme physiological stress. During these periods, there can
be increased production of reactive oxygen species which can be harmful to the host.
In aerobic organisms, oxygen is reduced to water, the end product of
mitochondrial respiration. During this process, there is leakage of single electrons
leading to the partial reduction of 02 to superoxide anion (0 2.-) (Frei, 1994). These
free radicals (reactive oxygen, nitrogen and chlorine species) due to their unpaired
electrons are highly unstable and reactive. In addition to the electron transport, there
are various endogenous pathways for the production of reactive oxygen species
(ROS): Reduced nicotinamide-adenine dinucleotide phosphate (NADPH) oxidase in
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phagocytic cells (neutrophils and monocytes), xanthine oxidase,

epinephrine, and

quinoid substrates, such as coenzyme QlO and the cytochrome P450 system (Frei,
1994).
Beneficial aspects of ROS

Recent work on reactive oxygen species has revealed their beneficial aspects to
the host in disease prevention by assisting the immune system in cell signaling and
playing an essential role in apoptosis (Seifried, et al., 2007). Innate immune response,
characterized by the production of ROS within the phagocytic cells such as
neutrophils and macrophages is a crucial event in the phagocytosis and subsequent
destruction of the invading pathogen (Bogdan, et al., 2000, Droge, 2002). During the
respiratory burst, high levels of superoxide anions and hydrogen peroxide are
produced by NADPH oxidase which is also a part of innate defense (Segal, et al.,
2000). Hence, any activities that can block the production of ROS may result in
increased bacterial or fungal infections and increased mortality (Deforge, et al., 1993,
Segal, et al., 2000).
Deleterious aspects of ROS

The ROS formed during cellular processes may damage various biological
macromolecules, which includes damage to cellular membranes and lipoproteins by
lipid peroxidation, damage to proteins leading to structural changes, altered enzyme
activity and oxidative damage to DNA (Frei, 1994).
Antioxidants protect biological macromolecules from harmful effects of free
radicals either by scavenging the free radicals or by stopping free radical propagation
(Frei, 1994).

The antioxidant defense can be classified into enzymatic and
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nonenzymatic defenses.

Enzymatic includes Glutathione peroxidase (GsHPx) ,

catalase and superoxide dismutase (SOD) whereas nonenzymatic includes vitamin E,
vitamin C, ~-carotene and others (Evans and Halliwell, 2001).
VITAMINE

Vitamin E is a lipid soluble vitamin discovered in 1922 by Evans and Bishop
(Evans and Bishop, 1922). The active substance was isolated by Evans in 1936 and
was named as tocopherol which means "to bear offspring" as it was shown to prevent
sterility in rats (Emerson, et al., 1936). Since then, there has been extensive research
directed towards the mechanism and role of this multifunctional vitamin.
Structure of vitamin E

Vitamin E was first found in wheat germ oil and lettuce (Wang and Quinn,
1999). Vitamin E is also present in many plants, legume and fruit sources in nature
(NIH, 2009).

Vitamin E occurs as eight naturally occurring compounds

called

tocopherols and tocotrienols which differ in their biological activity (IUPAC-IUB,
1982) and the saturation of phytal side chain (Fig. 2). Different isoforms of vitamin E
include a-,

~-,

y-, 8-tocopherols and a-, ~-, y-, 8-tocotrienols (Kayden and Traber,

1993). Within each group a-,

~-,

y-, 8 are designated depending on the position and

number of methyl groups on the aromatic ring. Among all the forms of vitamin E, atocopherol has the highest biological activity attributed to a higher number of methyl
species that can scavenge the peroxyl radicals (Meydani, 1995).
Metabolism of vitamin E

As a fat soluble vitamin, the metabolism of vitamin Eis closely related to other
lipids and lipoproteins. In the small intestine, vitamin E is integrated into micelles
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which are composed of products of lipid hydrolysis, biliary secretions and dietary
lipids (Rimbach, et al., 2002). Micelle formation facilitates the absorption of vitamin
E and the action of pancreatic lipases which further aid in the absorption of vitamin E
into the enterocytes lining the intestinal lumen (Brigelius-Flohe and Traber, 1999).
Vitamin E is then packaged in the enterocytes along with other lipids, as chylomicrons
or chylomicron remnants, which are absorbed and carried by lymphatic circulation to
the liver (Bjomeboe, et al., 1987, Kayden and Traber, 1993, Traber, et al., 1986).
In the liver a- tocopherol is secreted into plasma in conjunction with very low
density lipoprotein (VLDL) (Cohn, et al., 1988). Alpha tocopherol associated with
VLDL in plasma can have different fates, it can either be transferred to LDL during
VLDL catabolism, get delivered to HDL during lipolysis or get transferred back to the
liver via VLDL remnants (Kayden and Traber, 1993). Liver regulates the secretion
and excretion of different forms of tocopherol.

The other forms of ingested

tocopherol, other than alpha tocopherol undergoe rapid clearance via bile (Kayden and
Traber, 1993). This preferential secretion of alpha tocopherol by liver is due to atocopherol transfer protein (a-TTP) as observed in knockout mice experiments
(Leonard, et al., 2002) and patients who were deficient in a-TTP (Traber, et al., 1990)
The major route of excretion for vitamin E is through the feces. Urinary excretion of
vitamin E in the form of carboxyethyl-hydroxychromane (CEHC) metabolites also
takes place in case of excess vitamin E intake (Brigelius-Flohe and Traber, 1999).
Mechanism of action of vitamin E

Vitamin E is widely known for its effective chain breaking antioxidant
function (Azzi, 2007). Vitamin E is present in all biological cell membranes and
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offers protection to the cell membrane lipids from peroxidation and maintains their
structural integrity. Cellular integrity is very important for receiving and responding
to the messages needed to produce an effective immune response (Latshaw, 1991).
Although, vitamin E content varies throughout the body, it is present in highest
concentrations in tissues with high lipid content (Combs, 1991)

(e.g., liver and

adipose tissue). It is also known for scavenging the free radicals produced during
normal cellular metabolism and during various immune mechanisms like phagocytosis
and respiratory burst (Hogan, et al., 1993a).
Vitamin E (a - TOH) works as an antioxidant by donating a hydrogen group to
the unstable free radicals (ROO-) forming stable lipid hydroperoxide (ROOH) thereby
protecting the cell membrane by maintaining its integrity and stability (Fig. 3). During
this process there is production of a- tocopheroxyl radical (a TO-) which is stable as
compared to the other free radicals. This alpha tocopheroxyl radical is restored back
to vitamin E in the cell by vitamin C, glutathione, ubiquinone and other pathways
(Packer, et al., 1997).
Non antioxidant functions of vitamin E

Alpha tocopherol inhibits protein kinase C (PKC) activity, a signaling
molecule that can regulate cell proliferation. This specific inhibitory effect on cell
proliferation contributes to the anti-atherosclerosis and anti-tumor effects of vitamin E
(Azzi, et al., 2002). Vitamin E also inhibits platelet aggregation by Protein kinase C
dependent mechanism and prevents thrombus formation in the blood vessels (Azzi, et
al., 2002). Vitamin E inhibits prostaglandin E2 production by macrophages, which
has a suppressive effect on T cells (Meydani, et al., 1997, Meydani, et al., 1986).
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Supplementation of vitamin E to old mice enhanced the expression of cell cycle
related proteins that aid in entering into mitotic phase and help in DNA replication
(Pelizon, 2003, Quadri, et al., 1998). In cancer cells, vitamin E was hypothesized to
prevent the proliferation of cells by down regulating cell cycle regulatory proteins (Ni,
et al., 2003, Turley, et al., 1997)

Vitamin E deficiency
A vitamin E concentration < 2ug/ml in serum/plasma is considered deficient
(NRC, 2007).

Vitamin E deficiency, alone or in conjunction with selenium

deficiency, has been linked to several clinical syndromes that are variably manifested
in a wide variety of species.

The most common and well described clinical

manifestation due to the deficiency of vitamin E and selenium is white muscle disease
(WMD), also known as nutritional muscular dystrophy in lambs, calves, and foals
(Abutarbush and Radostits, 2003). In lambs, the clinical signs due to WMD include
weakness, stiffness, inability to stand and curved back (Deger, et al., 2008).
Postmortem examination reveals necrosis, mineralization, and fibrosis of the skeletal
and cardiac muscle (Beytut, et al., 2002, Bostedt and Schramel, 1990). Vitamin E
deficiency is thought to be the cause of equine motor neuron disease and equine
degenerative

myeloencephalopathy

m

equines,

exudative

diathesis

and

encephalomalacia in poultry, mulberry heart disease and hepatitis dietetica in pigs, and
hepatic necrosis in rats.
Previous studies have shown that a deficiency of vitamin E has negative
impact on both the humoral and cell mediated immunity.

A study on vitamin E

deficient animals showed decreased natural killer cell (NK) activity and decreased
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phagocytosis by polymorphonuclear cells (Moriguchi and Muraga, 2000). Pigs and
dogs fed a diet deficient in selenium and vitamin E decreased lymphocyte proliferation
to mitogens (Lessard, et al., 1993). A study in selenium and vitamin E deficient mice
reported decreased resistance to gastrointestinal nematode infection (Smith, et al.,
2005).
A deficiency in antioxidant nutrients like vitamin E and selenium can increase
viral pathogenicity by decreasing immune response of the host which in turn can cause
mutations in a benign virus transforming it into a virulent strain (Beck, et al., 1994,
Beck, et al., 2005). This new aspect of nutrition altering viral pathogenicity was a
breakthrough in nutritional immunology.
Toxicity of vitamin E
Evidence of vitamin E toxicity is rare. According to NRC, 2006 up to 70
IU/Kg body weight (BW)/day is considered safe. However, vitamin E during the
process of scavenging free radicals forms tocopheroxyl radical which can act as
prooxidant when given in large quantities and which, if not restored back by vitamin C
or glutathione, can produce hcumful effects (Bell and Grochoski, 2008). Recently,
some researchers have reported increased mortality and cardiovascular diseases with
higher levels of vitamin E supplementation in humans (Clarke, et al., 2008).

VITAMIN E AND IMMUNITY
The effect of vitamin E on disease resistance has been studied in a wide variety
of animal species.

Vitamin E has been shown to modulate both the innate and

adaptive components of the immune system (Han, et al., 2006, Hogan, et al., 1992,
Singh, et al., 2006, Tanaka, et al., 1979, Tengerdy, et al., 1973). Studies by Meydani
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and Moruguchi demonstrated that vitamin E is required to maintain immune function
in the elderly (Meydani, et al., 1990) and improve the decline in cellular immunity that

occcurs with aging (Meydani, et al., 1986, Sakai and Moriguchi, 1997).

Vitamin E and innate immunity
Vitamin E supplementation has been shown to improve neutrophil function in
cows during calving period (Hogan, et al., 1990, Hogan, et al., 1992). Vitamin E in
combination with selenium increased neutrophil function in dairy cows (Gyang, et al.,
1984). A study conducted on geriatric horses supplemented with parenteral vitamin E
showed an increase in the level of bacterial killing in supplemented horses but lack of
significant effect on serum lysozyme activity (Petersson, Unpublished data). Sows fed
72

ru

of a- tocopherol/kg of feed, during pregnancy and lactation improved their

piglets serum lysozyme concentrations at 1 week of age, but had a negative impact
when they were fed with 202 IU/kg of feed (Babinszky, et al., 1991).
Selenium and vitamin E supplementation in the cow during late stages of
pregnancy (Lacetera, et al., 1996) and during the periparturient period (Weiss, et al.,
1990) increased GSH-Px activity in cows and their calves. Supplementation with
3000 IU/day of vitamin E during transition period in cows prevented the decrease in
superoxide anion production in neutrophils and Interleukin- I production when
compared to control cows (Politis, et al., 1995). Rats fed 100-2500 mg/Kg diet of
vitamin E showed increased phagocytic activity in alveolar macrophages, which was
dose dependent (Moriguchi, et al., 1990). However, vitamin E did not influence the
measures of mammary macrophage function in dairy cows (Politis, et al., 1995,
Politis, et al., 1996). Incidence of clinical mastitis (Smith, et al., 1984, Weiss, et al.,
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1997), retained placenta (Erskine, et al., 1997, Miller, et al., 1993) and metritis
(Erskine, et al., 1997) was reduced in cows supplemented with oral or parenteral
vitamin E.

More recently, a study conducted on murine peritoneal macrophages

showed that supplementation with vitamin E can safeguard the morphology of
immune cells like macrophages from the effect of peroxidative agents (Kaur, et al.,
2009). Studies supplementing vitamin E and selenium during dry period in ewes
(Morgante, et al., 1999), reported an increase in blood glutathione peroxidase activity,
but no significant effect on plasma lysozyme activity.
Vitamin E and Humoral immunity

In 1973, Tengerdy et al. supplemented mice with vitamin E (60-180 mg/Kg of
feed) and reported a 30-40% enhancement in the humeral immune response against
sheep red blood cells (SRBC) and tetanus toxoid antigens (Tengerdy, et al., 1973). In
this study, they demonstrated that the increase in humoral immunity was the primary
immune response, which includes early stage of immunocyte development and
proliferation. Dietary supplementation of vitamin E (300 mg/kg diet) to chickens
significantly increased survival rate upon challenge with E. coli and the protection was
attributed to increased antibody production and increased phagocytosis (Tengerdy and
Brown, 1977).
Studies during gestation period Supplementation with parenteral selenium (5mg/100

kg BW) and dl a-tocopherol acetate (25 IU/Kg BW) during the late stages of
pregnancy, did not influence plasma IgG concentrations of cow or their calves
(Lacetera, et al., 1996). In agreement with the previous study, pigs supplemented with
vitamin E at 22- 88 IU/ kg feed during gestation and 55- 220 IU/kg feed during
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lactation had no effect of vitamin E on total IgG, IgM, IgA in plasma, colostrum and
milk of gilts and their piglets (Nemec, et al., 1994). Gentry et al. reported that lambs
from ewes injected with 1500 IU vitamin E, 21 d before parturition, had greater
concentrations of serum IgG than lambs born to control ewes (Gentry, 1992a).
Conversely, supplementation of pregnant ewes with 400 IU of vitamin E/ewe/day, 32
days to 0 day prior to lambing, did not have any effect on ewe and lamb serum IgG
(Daniels, et al., 2000).

Studies in young animals Calves supplemented with oral vitamin E and C alone or in
combination did not produce any significant increase in IgG and IgM response
(Hidiroglou, et al., 1995). The IgG results were in agreement with Reddy et al. in
calves receiving 1400 -2800 IU of oral dl-a-tocopherol acetate and 1400 IU dl-atocopherol parenterally but IgM was significantly higher in the orally supplemented
calves (Reddy, et al., 1986). In a recent study, neonatal calves supplemented with
2000 IU of parenteral vitamin E weekly, starting at birth until the age of two weeks,
showed an increase in the total IgG concentration and IgM concentration on day 22
(Pekmezci and Cakiroglu, 2009).
Vitamin E supplementation and vaccination response
Vaccination is an important tool in controlling and eradicating a disease.
Immunological responses to specific pathogens can be increased by vaccination.
Hence, the greater the production of antibodies against an antigen, the greater the
protection offered against the disease.
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Research in pigs, chickens, and other animals

Dietary vitamin E supplementation at 100 IU/ Kg of feed to 6-8 wk old pigs
yielded enhanced primary and secondary immune response against E.coli bacterin
when compared to the pigs receiving the NRC recommended amount of 20 IU/Kg of
feed and control pigs (Ellis and Vorhies, 197 6). This increase in humoral response in
vitamin E supplemented pigs was two to threefold greater than control pigs. Horses
supplemented with vitamin E alone or a combination of vitamin E and selenium
produced higher antibodies against tetanus toxoid and equine influenza virus
(Baalsrud and Ovemes, 1986). The findings of these studies are similar to a more
recent study on geriatric horses supplemented with vitamin E, which showed increased
antibody production against tetanus toxoid vaccination (Petersson, Unpublished data).
Serum antibodies in chickens vaccinated against Newcastle Disease virus were
associated with higher hemagglutination inhibition titer and total immunoglobulins in
vitamin E and selenium supplemented chickens compared to an unsupplemented
group (Singh, et al., 2006).

Dogs supplemented with parenteral vitamin E and

selenium showed increased antibody titer against Taenia hydatigena and IgG
concentration compared to controls (Kandil and Abou-Zeina, 2005)
Research in Cattle

Calves supplemented with 4180 IU/animal of oral vitamin E at weekly
intervals showed increased IgM levels (Reddy, et al., 1986) but no change in total IgG
concentrations (Reddy, et al., 1986). Further work by the same group reported higher
antibody titers to Bovine herpes virus- I vaccine in the calves supplemented with
vitamin Eat 125 IU/day/calf compared to the calves receiving 250 IU, 500 IU and the

15

control calves (Reddy, et al., 1987). Parenteral supplemenfation of vitamin E and
selenium to the steers enhanced their humoral immune response against Pasteurella
hemolytica vaccination (Droke and Loerch, 1989). A combination of selenium (0.1

mg Se/kg bodyweight) and vitamin E (a-tocopherol acetate, 8 U/kg BW), to the cows
during late pregnancy improved the production of specific antibodies against E.coli
bacterin (Panousis, et al., 2001).

A mixture of vitamin E and Freunds adjuvant

resulted in higher antibody response in serum and milk against E.coli bacterin
compared to Freund's alone as the adjuvant and control cows (Hogan, et al., 1993b).
Research in Sheep

Many of the studies evaluating the effect of vitamin E on immune response
have investigated the influence on antibody production.

Tengerdy et al. reported

increased antibody response against Clostridium perfringens in sheep supplemented
with 300 mg/Kg feed of dl a-tocopherol acetate (Tengerdy, et al., 1983). In the same
study, they reported that adjuvant vaccine containing a fraction of vitamin E was more
effective in producing antibody response than the oral supplementation. (Tengerdy, et
al., 1983). In agreement with this study, vitamin E when used as an adjuvant with
Brucella ovis vaccine provided greater protection to rams against epididymitis in

comparision with Freunds incomplete adjuvant or commercial bacterin vaccinated
rams (Afzal, et al., 1984, Tengerdy, et al., 1991). Vitamin E supplementation to sheep
at 1000 ID/animal orally in the form of capsules did not prevent infection with
Chlamydia or development of typical lung lesions, but it appeared to speed the

recovery from infection (Stephens, et al., 1979).
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Increased antibody response against parainfluenza-3 virus was seen in sheep
supplemented with a combination of selenium (0.2mg/Kg feed) and vitamin E (30
IV/Kg feed) (Reffett, et al., 1988). In contrast to this study, sheep supplemented with
selenium (0.1 mg/kg BW) had a significant increase in Chlamydia antibody response
but no effect was seen when selenium was given in combination with vitamin E
(Giadinis, et al., 2000). Also, supplemental vitamin E (d-a-tocopherol acetate, 400
IV/ewe/day) to the ewe during gestation period had no effect on the response to
vaccination against parainfluenza-3 virus (Daniels, et al., 2000).

Vitamin E and cell mediated immunity
Supplementation of vitamin E (800 mg dl-alpha-tocopheryl acetate for 30 d) to
healthy elderly subjects produced an increase in interleukin-2 production and
mitogenic response to concanavalin A (Meydani, et al., 1990). Another study in
elderly patients supplemented with vitamin E, significantly improved age-related early
T cell signaling events in naive CD4(+) T cells (Marko, et al., 2007). Increased T
helper cell activity was found in mice supplemented with vitamin E (Tanaka, et al.,
1979).

Vitamin E has been shown to inhibit prostaglandin E2 production from

macrophages enhancing cellular immunity (Moriguchi, et al., 1990, Romach, et al.,
1993).

Calves supplemented with vitamin E showed increased lymphocyte

proliferation when stimulated with mitogens (Reddy, et al., 1987). In agreement with
this study, vitamin E and selenium supplementation to pigs (Larsen and Tollersrud,
1981) and sheep (Larsen, et al., 1988b) also enhanced lymphocyte proliferation upon
mitogenic stimulation. However, Politis et al. did not find any effect of vitamin E on
lymphocyte proliferation in cows (Politis, et al., 1995).
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CONCLUSION

Results of studies exarmmng the effects of vitamin E supplementation in
ruminants are variable and limited, but have shown enough benefits for additional
investigation. Research undertaken in this dissertation is intended to enhance the
evolving database of knowledge on vitamin E supplementation in late gestation sheep
and its effects on innate and humoral functions of ewes, their newborns and
vaccination response.
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Table 1.1. Summary of literature on vitamin E in cattle
Studr subjects VE dose
Calves
2000IU/day/weekly

Route
Parenteral

Duration
At birth, 7 and 14 d
of life

Calves

VE-900, 1800, 2700
JU

Parenteral

Pregnant cows

Se(0.05 mg/kgBW)
and VE
(0.25JU/kgBW)

Parenteral

At birth upto 12 wks
of age (3 wk
interval)
3 & 1.5 wks before
calving

Effect
Authors
IgM at day 22 of age: Pekmezci et al
(2009)
i
JgG: i
JgG Hidiriglou et al
Titer to KLH (1992)
At 2700 IU JgM: i
GSH-Px of dam & Lacetera et al
(1996)
calves: i
JgG of dam & calves

Pregnant Cows

3000 JUVE

Parenteral

Calves

125 JU/day/calf

oral

at 10 d and 5 d prior
to claving
Birth to 24 wks of
age

N eutrophils killing Hogan et al,
(1992)
ability: i
JgG against BHV 1: j Reddy et al (1987)

Table 1.2. Summary of literature on vitamin E in sheep

Study subjects

VE dosage

Route

Duration

Effect

Authors

Pregnant sheep

400
IU/ewe/day,
daily
1500 IU/ewe

oral

32 d before
lambing

Ewe, lamb, colostral IgG Anti PB titers -

Daniels et al
(2000)

Parenteral

21 d before
lambing
70 d period from
the age of 2 mts
During vaccn
period
4.5 mts prior to
parturition

Lamb Serum IgG: j
Colostral IgG: SerumlgG Anti PB titers:jsec
immune response
GSH-Px activity: j
Serum & colostral IgG Anti tetanus toxoid: j

Gentry et al
(1991)
Reffet et al
(1988)

Chlamydia psitaci titres -

Giadnis et al
(2000)

Pregnant sheep
Lambs

30 IU/Kg feed
(ace NRC
1985)

oral

Pregnant sheep

75
IV/day/sheep

oral

Sheep

1500 IU/ewe

oral

v

,)

6 weeks
· Weekly interval

Larsen et al
(1988)
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CHAPTER2:
Influence of Vitamin E on Innate and Hum oral components of the Immune
system of Pregnant Ewes and their Lambs

ABSTRACT
The effect of parenteral administration of vitamin E during the pregnancy and
lactation period of ewes and their lambs on innate and humoral components of the
immune system was investigated in a 3 part study.

1.) Pregnant/Lactating ewes:

Fifteen pregnant Dorset sheep were supplemented with vitamin E (30 IU d-atocopherol /Kg body weight (BW), E, n=lO) or placebo (emulsified base, P, n=5) from
the last trimester of gestation through weaning. Blood and colostrum were analyzed
every 2 wk for a-tocopherol, selenium, glutathione peroxidase activity, lysozyme
activity, total IgG and IgG antibodies against tetanus toxoid. 2.) Lambs (0-8wks):
Lambs born to E and P supplemented ewes received either vitamin E (30 IU d-atocopherol /Kg BW) or placebo (emulsified base) every 2 weeks from birth through 8
wk of age. This resulted in four treatment groups: E/E (n=lO), E/P (n=l l), PIE (n=4),

PIP (n=5). The lambs were sampled every other week and their blood was analyzed as
for the ewes. 3.) Lambs (Vaccination period): When the youngest lamb reached 8
wks of age all lambs were vaccinated as a group against Clostridium perfringens and
Clostridium tetani. Booster vaccinations were given 4 wk later. Blood was sampled

prior to primary vaccination, 1 wk post vaccination and then every 2 wk until 7 wk
post vaccination. Results: Pregnant/Lactating ewes: Serum vitamin E concentrations
mcreased over time in supplemented ewes as compared to placebo ewes. Colostrum
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vitamin E levels were also increased in supplemented versus placebo ewes. Vitamin E
supplementation did not influence plasma selenium, glutathione peroxidase activity
and serum lysozyrne, IgG and IgG against tetanus toxoid in the serum or colostrum of
ewes. There were fluctuations within treatment in the production of IgG in response
to parturition. Lambs (0-8wks):

Lambs directly supplemented with vitamin E in

addition to maternal supplementation (E/E) had higher levels of serum a-tocopherol
than the placebo group (PIP).

There were no differences in plasma selenium,

glutathione peroxidase activity, serum lysozyme, IgG and IgG against tetanus toxoid
concentrations between groups. There was a loss of maternal antibodies over time in
all lambs.

Serum lysozyrne activity was higher at birth, prior to ingestion of

colostrum, in lambs that received maternal vitamin E supplementation compared to the
lambs that received only direct vitamin E supplementation.

Lambs (Vaccination

period): Serum a-tocopherol levels increased in lambs that received direct vitamin E
supplementation (E/E and PIE) irrespective of maternal supplementation (PIP and
E/P). Plasma selenium, glutathione peroxidase activio/, serum lysozyme and IgG did
not differ between treatment groups. There was an increase in the production of IgG
against tetanus toxoid in response to booster vaccination in PE lambs. Conclusions:
Supplemental vitamin E to the ewes and lambs, at 30 IU/Kg BW, had a modest effect
on parameters used in this study to assess innate and humoral immunity.
(Key words: vitamin E, ewe, IgG, tetanus toxoid)

INTRODUCTION

Vitamin E has been shown to modulate immune function in several species of
animals (Meydani, et al., 1986, Reddy, et al., 1987, Tengerdy, et al., 1983).

The

maternal immune system during the transition period is under increased physiological
stress.

The stress during pregnancy and increased metabolic demands during

parturition and lactation result in increased production of reactive oxygen species
leading to oxidative stress and a subsequent reduction in neutrophil function, antibody
responses and cytokine production by immune cells (Spears and Weiss, 2008). Efforts
to enhance immune function of pregnant animals through vitamin E supplementation
have been met with varied results (Daniels, et al., 2000, Gentry, 1991, Giadinis, et al.,
2000, Larsen, et al., 1988).
Maternal immune function will impact their offspring through maternal
transfer of immune cells in the colostrum. The immune response of lambs to maternal
vitamin E supplementation has been varied (Daniels, et al., 2000, Gentry, 1992) with
either no effect (Capper, et al., 2005, Daniels, et al., 2000) or an increased effect
(Gentry, 1992) on serum immunoglobulin G (IgG) reported.
It has been generally assumed that there is no significant transfer of vitamin E

across the placenta in ruminants (Njeru, et al., 1994).

Recently however,

supplementation of dietary vitamin E to ewes from 6 wks prepartum to 6 wks
postpartum enhanced serum a-tocopherol levels in muscle tissue of lambs at birth
even though plasma tocopherol concentration did not differ between groups (Capper,
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et al., 2005). The potential of vitamin E supplementation of the ewe and her offspring
to enhance immune function is an area that warrants further study.
Therefore, the present experiment was designed to determine the effect of: 1.)
Vitamin E supplementation on immune function in pregnant and lactating ewes; 2.)
Direct vitamin E supplementation to the lamb superimposed on maternal
supplementation on innate and adaptive immune function in lambs from birth through
7 months of age.
MATERIALS AND METHODS
Animals

Pregnant/lactating Dorset ewes (n= 18) ranging from 1-9 yrs of age and their lambs
(n=30) were included in this study.

All the ewes and lambs were maintained,

treatments were administered, and samples were collected in accordance with the
Institutional Animal Care and Use Committee (IACUC) of the University of Rhode
Island. Ewes were fed with hay and grain whereas lambs had a free choice of feed.
Feed analysis for various minerals, vitamin E and selenium are shown in Table 2.1.
Body condition and weight were monitored for the ewes and lambs throughout the
study.
Study Design

Pregnant/Lactating Ewes. Pregnant Dorset sheep were randomly assigned to

receive either vitamin E (30 IU d-a-tocopherol /kg body weight (BW), E, n=lO) or
placebo (P, n=8). The mean age of the ewes was 3.9 (±0.75) and 5.5 (±0.89) for
vitamin E and placebo groups respectively.

Intramuscular injections of d-a.-

tocopherol (Neogen, Lexington, KY) or equivalent quantity of placebo (emulsified
base) were given every two weeks from the last trimester of gestation until weaning of
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lambs at 3-4 months of age. Ewes were administered a yearly booster vaccination for
Clostridium tetanus and Clostridium perfringens (C+D) (Colorado Serum Company,

Denver, CO) approximately 6 weeks prior to parturition.

Lambs (0-8wks). At birth, lambs born to vitamin E or placebo supplemented
ewes, were assigned to receive either vitamin E (30 IU d-a-tocopherol/kg BW) or
placebo (emulsified base) intramuscular injections from birth through 8 wk of age.
This resulted in four treatment groups: 1.) Maternal E, Lamb E (E/E, n=lO) 2.)
Maternal E, Lamb P (E/P, n=l 1) 3.) Maternal P, Lamb E (PIE, n=4) 4.) Maternal P,
Lamb P (PIP, n=5).

Following standard management practices all lambs received a

single sodium selenite injection (O.lmg/kg BW) at 1 day of age. Body weight was
monitored every two weeks throughout the study.

Lambs (Vaccination). When the youngest lamb reached 8 weeks of age, all
lambs were vaccinated as a group against Clostridium tetanus and Clostridium
perfringens C+D (Colorado Serum Company, Denver, CO). Secondary vaccinations

were administered 4 weeks later.

The lambs were transitioned to receive their

biweekly injections of vitamin E.(30 IU/Kg BW) or placebo (equivalent mls/Kg BW)
as a group until the end of the study.

Blood from lambs after vaccination was

collected on the day of initial vaccination, 1 week later and every two weeks until the
end of study. Lambs ranged from 8-14 wks of age at this start of this study period.

Sample collection
Blood samples were collected via jugular puncture from ewes every two weeks
throughout the study period and from lambs, at birth (prior to colostrum consumption),
weekly until one month of age and then every two weeks until 8 weeks of age. All
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blood samples were collected pnor to biweekly injections of d-a.-tocopherol or
placebo. All samples were analyzed for a.-tocopherol, selenium and glutathione
peroxidase (GSH-Px) as a measure of antioxidant status, lysozyme as a measure of
innate immunity, and IgG, and anti-tetanus toxoid IgG (IgGt) as a measure of humoral
immune status. Lamb weights were measured to monitor growth performance.
Blood was collected into a serum separator and EDTA vacutainers (Becton
Dickinson, Franklin Lakes, NJ) for serum and plasma respectively.

Tubes were

centrifuged (1750 x g) at 25° C for plasma and 4° C for serum. Colostrum from the
ewes was collected immediately after parturition. All the samples were stored at -80°
C prior to analysis colostrum was centrifuged at 24,400 g for 20 minutes at 4° C, the
fat layer removed, and the whey fraction was analyzed for lysozyme, IgG and IgG
against tetanus toxoid.
Alpha Tocopherol in Serum and Colostrum

Samples were analyzed for a.-tocopherol content using established procedures
at the Diagnostic Center for Population and Animal_Health (DCP AH, Lansing, MI).
Briefly, reverse phase HPLC (Hitachi, Pleasanton, CA) with a 3.5 um C18 column
(Waters Corp, Milford, MA) and acetonitrile: methylene chloride: methanol mobile
phase (70:20: 10) was used. Alpha tocopherol was detected at a wavelength of 292 nm
and results are expressed as µg/ml.
Selenium and GSH-Px in Plasma and Colostrum

Samples were analyzed at the USDA Grand Forks Human Nutrition Research
Center (Grand Forks, North Dakota) for selenium content and GSH-Px activity.
Selenium concentrations were determined with electrotherma atomic absorption
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spectrophotometry using a reduced Pd matrix modifier according to published
procedure (Clark, et al., 1996) and results are expressed as ng/ml.

GSH-Px was

assayed by the glutathione reductase-coupled assay (Paglia and Valentine, 1967) as
modified by Lawrence and Burke (Lawrence and Burk, 1976) using 0.25 mM H20 2 as
substrate. Results are expressed as nanomoles ofNADPH/min/mg of protein.
Lysozyme Activity

Lysozyme activity was determined by the radial diffusion of samples through a
suspension of live culture of Micrococcus luteus (ATCC 27141, Manassas, VA) in
M/15 phsophate buffered agarose, pH 6.3 following published procedure (Sotirov,
2005). The diameters of the lytic zones were compared with the lytic zones of the
standard, hen egg white lysozyme (Sigma Aldrich, St.Louis, MO).

Results are

expressed as µg of hen egg white lysozyme equivalent per ml.
IgG

A commercial ELISA kit (Bethyl Labs, Montgomerry, Texas) was used to
detect and quantify sheep lgG antibodies in the serum and colostrum. Briefly, rabbit
antisheep lgG antibody is coated onto plates and incubated followed by blocking with
0.05M tris buffered saline (Sigma-aldrich, St.Louis, MO) and addition of standard or
serum sample. Rabbit antisheep IgG labeled with horse radish peroxidase enzyme was
used as the detection antibody. Reaction terminated using stop solution (2 M H2So4)
and the absorbance is read at 450 nm. Results are expressed as mg/ml of serum.
lgG against tetanus toxoid

Antibodies to tetanus toxoid were determined according to (Rosskopf, et al.,
2005) with some modifications.

Briefly, 0.2 lf/ml (limit of flocculation units) of
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commercially available tetanus toxoid was coated onto 96 well plates and incubated
overnight at 4°C. Wells were blocked with phosphate buffered saline (PBS), followed
by addition of standards and samples diluted in PBS (0.01 M with 0.05 % tween 20).
Rabbit anti-sheep IgG horse radish peroxidase conjugated antibody (Bethyl Labs,
Montgomerry, Texas) was used as developing antibody, followed by the addition of
tetramethylbenzidine (TMB) susbtrate to the plates and incubated in dark for 15
minutes before the reaction was terminated by 1.25 M H2S04.
expressed as absorbance units at 450nm (OD

450

The results are

).

Statistical analysis

The mixed procedure in SAS (SAS Inst. Inc., Cary, NC) was used to analyze
serum a-tocopherol, lysozyrne activity, antibody concentrations, selenium, and GSHPx. The random effect of ewe or lamb was accounted for with a repeated measures
approach.

All outcome variables were assessed for normality.

A logarithmic

transformation was applied to non-normally distributed data. The appropriate error
structure was assessed and applied for each outcome variable. Independent variables
offered into each model included age, sex, treatment, and time. The interaction of
treatment and time was evaluated for each model.

Variables were removed by

bacJ:cwards elimination based on order of least significance. Tukey's adjusted P-values
were calculated for each variable to adjust for multiple 2-way comparisons within
each model.

Once the final model was chosen, residuals were checked for

homoscedasticity, outliers, leverage cases, and normal distribution. Student's t-test
was used to statistically analyze colostral content of a-tocopherol, selenium, GSH-Px
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activity, lysozyme activity, IgG and IgGt. Significance was defined for all tests as P :S
0.05.

RESULTS
Three ewes from the placebo group, though testing positive on ultrasound, did
not lamb and therefore were removed from the study. This resulted in 5 animals in the
placebo group (5.8±1.11 yrs) and 10 animals in the vitamin E group (3.9±0.75 yrs).
Feed analysis of the mixed grass hay and grain fed to sheep and lambs is shown in
Table 2.1.
Pregnant/Lactating Ewes.

Serum a-tocopherol increased over time in vitamin E supplemented
ewes (P :S 0.001, Fig. 2.1) as compared to placebo supplemented ewes. There was
also a treatment

*

week interaction for serum IgG (P :S 0.05, Fig. 2.2). Placebo

supplemented ewes had a greater concentration of plasma selenium than vitamin E
supplemented ewes (P :S 0. 05, Table 2.2). There was no effect of treatment or
treatment by week interactions for plasma GSH-Px activity, serum lysozyme activity
and serum IgGT. The colostrum from vitamin E supplemented ewes contained greater
(P :S 0.05, Table 2.2) amounts of a-tocopherol than placebo supplemented ewes.

There was no effect of vitamin E supplementation on colostral selenium, GSH-Px
activity, lysozyme activity and IgG against tetanus toxoid concentrations. Treatment
means(+/- SE) for all variables is shown in Table 2.2.
An increase in IgG concentrations were seen in vitamin E supplemented ewes

after their yearly booster vaccination against Clostridium tetanus and Clostridium
perfringens (P :S 0.05, Fig. 2.2). There was no vaccination response in the placebo
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supplemented ewes.

There was a decrease in serum IgG in both vitamin E and

placebo supplemented ewes during the transition period that was more pronounced in
the placebo supplemented ewes (P ::S 0.05, Fig. 2.2).
Plasma selenium, plasma GSH-Px activity, serum lysozyme activity, and serum
IgGT increased over the length of the study period (P ::S 0.001, Table 2.3).
When the effect of ewe age on the statistical model was determined plasma
selenium concentrations were higher (P ::S 0.05) in younger ewes (::S 5yrs) as compared
to older ewes

(~

7 yrs) and serum IgGT concentrations was greater in older than

younger ewes. There was no effect of age on serum a-tocopherol, lysozyme activity,
IgG and plasma GSH-Px acitivity. The effect of age for all the variables is shown in
Table 2.4.
Lambs (0-8wks).

Serum a-tocopherol was greater in EE lambs than PP lambs (P ::S 0.05, Fig. 2.3)
Lambs receiving maternal vitamin E supplementation but no direct supplementation
(E/P) had elevated serum a-tocopherol over that of PIP that did not reach the level of

significance (P

=

0.0685). At birth, before suckling serum lysozyme activity was

higher (P ::S 0.001, Fig. 2.4) in lambs that received maternal vitamin E supplementation
compared to the lambs whose dams received placebo.

There was no effect of

treatment or treatment by week interaction for the plasma selenium and GSH-Px
activity, and serum IgG and IgGT. Mean (+/- SE) of all variables by treatment is
shown in Table 2.5.
There was an effect of week (P ::S 0.001, Table 2.6) for serum vitamin E, lgG,
lgGT, plasma selenium and GSH-Px activity. Serum IgG and IgG against tetanus
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toxoid decreased over time in all lambs regardless of supplementation. Glutathione
peroxidase and plasma selenium concentration increased over the length of the study.
Lambs (Vaccination Period).

Serum a-tocopherol increased over time in lambs receiving direct vitamin E
supplementation (EE and PE) as compared to lambs supplemented with placebo (EP
and PP, P :'.S 0.001, Fig. 2.5). Secondary vaccination against Clostridia tetani elicited a
strong response in lambs receiving direct vitamin E supplementation but no maternal
supplementation (PE, P :'.S 0.001, Fig. 2.6).

There was no significant increase in

production of antibody production in response to the secondary vaccination against
Clostridia tetani in all other treatment groups. There was no effect of treatment or

treatment by week interaction for the variables, selenium, GSH-Px activity, lysozyme
activity and IgG. Mean± SEM for all the variables by treatment is shown in Table

2.7.
There was an effect of week of study (P :'.S 0.001, Table 2.8) for plasma
selenium, GSH-Px activity, serum IgG and IgGT. Glutathione peroxidase activity and
plasma selenium decreased in all lambs during the vaccination period. There was an
increase in total serum IgG levels following primary and secondary vaccination in all
the lambs.
When the effect of lamb age, at the start of the vaccination period, on the
statistical model was determined plasma selenium concentration were greater (P :'.S
0.05) in older lambs(~ 12 wks) compared to younger (:'.S 12 wks) lambs. We did not
observe an effect of age on serum a-tocopherol, lysozyme activity, IgG, IgGT and
plasma GSH-Px acitivity. Mean± SEM by age oflamb at the start of the vaccination
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period is shown in Table 2.9. When the effect oflamb sex on the statistical model was
determined ewe lambs had a higher concentration of serum a-tocopherol (1.29 ± 0.06
µg/ml, p:::; 0.001) than ram lambs (0.98 ± 0.05 µg/ml).There was no effect of sex for
any other study variables.
DISCUSSION
Pregnant/Lactating Ewes

As expected, there was an increase m serum a-tocopherol levels in
supplemented versus placebo ewes. Serum or plasma a-tocopherol

levels are

routinely used as indicators of vitamin E status. Serum a-tocopherol concentrations >
4 µg/ml are considered adequate, 2-4 µg/ml is marginal and animals with < 2 µg/ml
are considered deficient according to cattle studies (Bass, et al., 2001). In our study,
we observed marginally deficient tocopherol levels at baseline in all ewes and in
placebo ewes throughout the study. Vitamin E supplemented ewes reached the 4
ug/ml threshold by the end of the study.
Placebo ewes had higher plasma selenium . levels compared to vitamin E
supplemented ewes. The ewes in both the treatment groups were having adequate
levels of selenium in their plasma (> 1OOng/ml). Vitamin E did not influence plasma
GSH-Px activity but the activity reached peak around parturition. This increase may
be due to the increased oxidative stress around parturition.

The plasma GSH-Px

activity levels are in agreement with those of Reffet et al. (1988) in lambs who
received selenium supplementation. Ewes supplemented with parenteral vitamin E
(7.5 ID/Kg BW/2 wks) and selenium (0.lmg/Kg BW/2 wks) one month before
lambing reported an increase in blood GSH-Px activity (Morgante, et al., 1999). The
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vitamin E supplemented in this study was less than the dose of supplemental vitamin E
administered in our study. The differences in the GSH-Px activity can be attributed to
the selenium injections given before lambing. As selenium is an integral part of the
enzyme GSH-Px, supplemental selenium might have a direct influence on the GSH-Px
activity in the morgante et al. study. In the present study, selenium and GSH-Px
activity were measured to assess antioxidant status of the animal as the soil in
northeast regions are considered as deficient in selenium levels. However, the ewes in
this study were not deficient in selenium levels.
To date, there has been very little research on the effects of vitamin E on innate
immunity in ruminants. In the present study, vitamin E had no influence on serum
lysozyme activity. A similar trend was observed in ewes supplemented with vitamin
E (7.5 IU/Kg BW/2 wks) and selenium (O.lmg/Kg BW/ 2wks) one month before
lambing (Morgante, et al., 1999) and supplementation with vitamin E (15 IU/kg BW)
to horses (K.H. Petersson, Unpublished data).

The above reported studies

administered lower dose of supplemental vitamin E compared to our study. Lack of
significant effect on serum lysozyme concentrations in the present study suggests that
oxygen independent killing mechanisms are insensitive to vitamin E status (Turner
and Finch, 1990).
Although there was no effect of vitamin E supplementation on serum IgG
levels, the ewes in both the treatment groups behaved differently over time. Placebo
ewes did not show an increase in IgG levels against Clostridium tetanus and
Clostridium perfringens vaccination, whereas vitamin E supplemented ewes showed

vaccination response. There was decrease in IgG levels around parturition for both the
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groups, but the immunosuppression occurring during this period appeared to be
diminished in the vitamin E supplemented ewes compared to placebo ewes. Lack of
treatment effect can possibly be due to the small sample size of the placebo ewes
which might have masked the effect of vitamin E during parturition. In agreement
with our findings, Daniels et al. (2000) reported that oral vitamin E (400 IU/ewe/day)

supplementation to the ewes during last trimester of gestation had no effect on serum
IgG levels.

This is in agreement with most of the studies conducted in cattle

(Lacetera, et al., 1996) sheep (Larsen, et al., 1988, Reffett, et al., 1988) with varying
doses of supplemental vitamin E.
As expected, ewes vaccinated against tetanus toxoid produced greater amounts
of tetanus specific antibodies in their serum. However, supplemental vitamin E did
not influence the production of lgGT antibodies. These results were not in agreement
with Larsen et al. (1988), who reported an increase in antibody titer to tetanus toxoid

in ewes with dietary vitamin E supplementation (75 IU of a-tocopherol acetate/day).
Although, the dose of supplemental vitamin E used in our study was higher than that
of Larsen et al. we did not see any enhancement in the antibody titer. Plausible
explanation for this difference could be the ewes in Larsen et al. study started with
much lower levels of serum tocopherol and were less than 2 µg/ml throughout the
study. And the supplemental vitamin E given at this period might have increased the
production of antibodies.

Also, the ewes were younger in Larsen et al. study

compared to our study where we had a range of ewes from 1-9 yrs of age.
The primary source of the nutrients for the ruminant newborns at birth is through
colostrum. Several studies (Bass, et al., 2001, Pinelli-Saavedra, et al., 2008, Weiss, et
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al., 1990) have shown that vitamin E supplementation to the dam during gestation
enhances a-tocopherol concentration in their colostrum.

These results were in

agreement with the present study. As placental transfer of immunity is limited in
ruminants, ruminant newborns are entirely dependent on their dam's colostrum for the
immunoglobulins. Transfer of adequate amounts of IgG from dams to newborns
minimizes the risk of infectious diseases until their own immune system comes into
play. However, in the present study, supplementing vitamin E to the ewes during last
trimester did not influence their colostral IgG and IgG against tetanus toxoid levels.
No effect of supplemental vitamin E on colostral IgG in the present study agrees with
the results reported in ewes supplemented with vitamin E (Daniels, et al., 2000) and
cattle (Lacetera, et al., 1996) during late gestation. Also, supplemental vitamin E to
ewes during the last trimester did not influence colostral lysozyme activity, selenium
and GSH-Px activity.
Lambs (0-8wks)

Serum a-tocopherol levels were higher in lambs that were directly
supplemented with vitamin E in addition to maternal supplementation (E/E) compared
to placebo (PIP). The lambs receiving only maternal supplementation (E/P) tended to
have higher means but did not reach significance level due to the small sample size of
the placebo lambs. This increase at week 1 can be due to the ingestion of colostrum
rich in vitamin E from supplemented animals. Interestingly, Capper et al. (2005)
reported increased tissue vitamin E levels in lambs at birth born to supplemented
ewes, even though their serum vitamin E levels were in low range. As we did not
sacrifice any lambs at birth we do not know whether the tissue content of vitamin E
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11.

was greater in the maternally supplemented lambs.

The serum a-tocopherol

concentrations in this study were in the deficient range; however, it is feasible that the
supplemental vitamin E was being stored in the tissues but not reflected in the serum
values. Further research is warranted in this area.
The selenium concentrations were low at birth but gradually increased over
time as the lambs were feeding on grain which has selenium. There was a treatment
by week interaction for the serum lysozyme activity in lambs. The lambs that were
born to supplemented ewes had higher serum lysozyme activity at birth compared to
the lambs that received only direct vitamin E supplementation. And the lambs were
having higher means for serum lysozyme activity at birth compared to the rest of the
life. This suggests that there might be increased lysozyme production in the fetal stage
which might be reflected in the serum levels at birth before taking colostrum. And the
vitamin E supplementation to the ewe might have influenced the production of
lysozyme within the fetus.
IgG and IgGT antibodies were not detectable at birth due to limited placental
transfer, but reached peak concentrations after the ingestion of colostrum at week 1 of
age. Thereafter, the maternal antibodies decreased overtime in spite of vitamin E
supplementation. During neonatal life, greater amounts of serum IgG has been
positively correlated with higher survival rates.

Supplementing vitamin E to the

newborns may help in reducing morbidity due to pathogens during the critical period
from the loss of maternal antibodies to the production of antibodies by the newborns
themselves.

There is controversy in the literature on the effects of supplemental

Vitamin Eon humoral immune response. Study by Gentry et al. (1992) reported that
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lambs from ewes injected with vitamin E, 21 d before parturition contained greater
concentrations of serum IgG than lambs born to control ewes. Gentry et al. explained
that though vitamin E did not influence colostral IgG levels, it might have influenced
the lambs ability to absorb immunoglobulins in the gut. However, we did not see such
an effect and our results were in agreement with the studies supplementing vitamin E
to ewes (Daniels, et al., 2000, Reffett, et al., 1988), cows (Lacetera, et al. , 1996) and
pigs (Nemec, et al., 1994) during gestation which did not influence their newborns
serum IgG levels. All of these studies vary in dose of supplemental vitamin E, interval
at which they are administered, breed and species of animal.
Lambs (Vaccination Period)

Serum a-tocopherol levels were higher in lambs that were directly
supplemented with vitamin E. The a-tocopherol concentrations in the E/E group
differed from E/P group on the initial day of vaccination but the rest of the groups did
not differ from each other on the initial day. The lambs that were supplemented
directly with vitamin E had significantly higher levels of tocopherol compared to the
lambs that received only maternal supplementation and the placebo lambs.

This

suggests that, the supplementation to the ewes during last trimester did not have a long
term influence on their lamb's serum a-tocopherol levels. Also, the lambs that did not
receive any supplementation (PP, EP) were having < 1µg/ml of serum tocopherol,
which is considered deficient.

The lambs that received direct vitamin E

supplementation had serum tocopherol levels ranging between 1-2.5 µg/ml which is
considered as marginal to adequate. Hence, vitamin E supplementation helped the
lambs to maintain adequate vitamin E status.
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Vitamin E did not influence plasma selenium and GSH-Px activity. Although,
there were no significant interactions for serum lysozyme activity the means of the
lambs that received only direct vitamin E supplementation tended to be higher than the
other groups. The lambs showed enhanced total IgG levels against both the primary
and secondary vaccination against C/ostridium tetanus and C/ostridium perfringens
but were not influenced by treatment. Reffet et al., (Reffett, et al., 1988) reported that
dietary supplementation of vitamin E to the lambs that were challenged with

I

Parainfluenza-3 virus did not show any significant effect on total serum IgG levels.
To date, there are very limited studies in supplementing vitamin E to the small
ruminants and its influence on antibody production to tetanus toxoid vaccination.
There was no treatment effect but the lambs that were directly supplemented with
vitamin E showed greater secondary immune response. Lack of significance might be
due to insufficient power from small sample size in PIE lambs.
In summary, supplementing vitamin E parenterally during late gestation, direct
supplementation to lambs did not appear to enhance the immune functions of sheep or
the lambs in this study.

Based upon these findings, parenteral vitamin E

supplementation at the rate of 30 IU/kg BW/2 wks which is equal to 2 IU/kg BW/day
to the ewes and lambs does not appear to be justified in improving their disease
resistance. Since the study has started, the recommendations by NRC for vitamin E
have been revised in 2007 (NRC, 2007) and the supplemental dosage is increased to
10 IU/K.g BW/day to protect the small ruminants from infectious diseases and to
extend the storage life of meat. Hence, it can also be possible that the vitamin E
supplementation used in this study might not be sufficient to elicit a significant
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immune response. Role of supplemental vitamin E in influencing immunocompetence
might be more pronounced when the animals are undergoing environmental and
pathogenic stress. Therefore, future studies taking small ruminants with sufficient
sample size and challenged with parasitic or bacterial pathogens might give a better
understanding of the effects of vitamin E on innate and humoral immune parameters.
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Table 2.1. Results from proximate analysis and vitamin E analysis from composite
1
feed samples collected over the study period .
Components
Grain Mix
Hay
DM, %

88.8

91.2

CP,%ofDM

20.65

12.1

NDF,%ofDM

29.7

59.2

ADF, %ofDM

10.95

35.5

Calcium,% ofDM

1.35

0.66

Phosphorus,% ofDM

0.88

0.31

Magnesium, % of DM

0.38

0.23

Potassium, % of DM

0.98

2.01

NEm, Meal/Kg of DM

1.89

1.28

NEg, Meal/Kg ofDM

1.26

Vitamin E, IU/Kg ofDM2

46.3

50

a-Tocopherol, µgig of
DM2
Selenium, µgig of DM2

42.14

45.47

1.13

0.03

0.71

I

1

Proximate analysis conducted by Dairy One Cooperative, Inc. (Ithica, New York).
Analyzed at the Diagnostic Center for Population and Animal Health (Michigan State
University, Lansing, MI).

2
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2.2. Mean (±SEM) of study variables in pregnant/lactating ewes supplemented with d-a-tocopherol (30 IU d-a.-tocopherol /kg
BW/2wks, n=lO) or placebo (emulsified base, n=5)1.

Variables
Serum/Plasma
Vitamin E (µg/ml) 2' 3
IgG (mg/ml) 2' 3
IgGT (OD4so)3,4
Lysozyme (µg/ml) 3

~

Placebo

Vitamin E

GSH-Px5•6 (run NADPH/min/mg protein)
Se (ng/ml) 6

2.14 ± 0.14
16.65 ± 1.34
0.97 ± 0.13
0.28 ± 0.01
0.97 ± 0.17
215 ± 9.3a

3.4 ± 0.2
19.03 ± 1.25
0.91±0.12
0.22 ± 0
0.88 ± 0.09
197 ± 7.4

Colostrum 7
Vitamin E (µg/ml)
lgG (mg/ml)
IgGT (OD 450)
Lysozyme (µg/ml)
GSH-Px (run NADPH/min/mg protein)
Se (ng/ml)

2.63 ± 0.53
57.27 ± 7.3
0.61±0.12
0.40 ± 0.14
0.24 ± 0.15
238 ± 19.7

13.36 ± 2.51 a
57.28 ± 4.51
0.56 ± 0.12
1.18 ± 0.38
0.22 ± 0.06
184 ± 22.07

Within a row, means with a superscript small letter differ (P < 0.05).
1
Variables were analyzed using PROC MIXED in SAS (SAS Inst. Inc, Cary, NC).
2
Treatment*week interaction is present (P ~ 0.05).
3
Measured in serum.
4
IgG against tetanus toxoid measured in absorbance at 450nm.
5
Glutathione peroxidase.
6
Measured in plasma.
7
Variables were analyzed using Student's t test

~

Table 2.3. Effect of week (Mean± SEM) on study variables in pregnant/lactating ewes1• 2
Week of Supplementation 3
Variables

0

2

4

6

IgGT(OD4so)5,o

0.59±
o.09•b

0.45±
0.06bc

l.l l ±
O. l 5dc

1.17±
0.11 dfg

Lysozyme6
(µg/ml)

0.19±
0.01 a

0.21 ±
0.01 •bcdef

0.2 ±
o.02•b

0.22 ±
o.02•bc

8

10

12

14

16

18

20

1.42 ±
0.11 flI

l.IO ±
0.12dcgi

0.92 ±
o.10•ij

0.83 ±
o.o<)ik

0.99 ±
0.11 degijk

1.04 ±
0.11 dcgij

0.84 ±
0.11 bjk

0.71 ±
0.09bk

0.22 ±
o.02•bcd

0.22 ±
o.02•bcd

0.25 ±
0.02bcd

0.26 ±
o.02•dc

0.22 ±
o.02•bcd

0.23 ±
o.02•bcd

0.3 ±

0.31

o.oi

24

±

0.03°f
GSH-Px4•7
(run of
NADPH/min/mg

0.42±
0.06

0.66 ±
0.01•b

0.8±
o.o8•bcd

0.7
± o•ce

1.04 ±
0.05cderg

1.34 ±
0.2r

1.03 ±
0.07df8

1.03 ±
0.06cderg

1.02 ±
O. l cderg

0.95 ±
o.05•hcdeg

1.02 ±
0.2abcdcg

of protein)

Within a row, means without a common superscript small letter differ (P < 0.001).
Supplemented with d-a-tocopherol (30 IU d-a-tocopherol /kg BW/2wks, n=IO) or placebo (emulsified base, n=5).
2
Variables were analyzed using PROC MIXED in SAS (SAS Inst. Inc, Cary, NC).
3
Vaccination against C/ostridium tetanus and C/ostridium perfringens at week 2 of supplementation.
4
Glutathione peroxidase.
5
IgG against tetanus toxoid measured in absorbance at 450nm.
6
Measured in serum.
7
Measured in plasma.
a-k
1

1.14 ±
0.25bdf

Table 2.4. Effect of age (Mean± SEM) on study variables in pregnant/lactating ewes.
J, 2

Variables

Age
> 7yrs
2.82 ± 0.17

3.06 ± 0.12

18.68 ± 0.64

17.94 ± 0.38

IgGT (OD4so)3,4

1.2 ± o.osa

0.81±0.04

Lysozyme (µg/ml)3

0.25 ± 0.01

0.22 ± 0.01

GSH-Px5' 6

0.97 ± 0.22

0.88 ± 0.09

Vitamin E (µg/ml)
IgG (mg/ml) 3

(nm NADPH/min/mg protein)

:S 5 yrs

Selenium (ng/m1) 6
188 ± 3.93
208 ± 2.3a
Within a row, means with a superscript small letter differ (P :S 0.05).
1
Supplemented with d-a-tocopherol (30 IU d-a-tocopherol /kg BW/2wks, n=IO) or
f lacebo (emulsified base, n=5).
Variables were analyzed using PROC MIXED in SAS (SAS Inst. Inc, Cary, NC).
3
Measured in serum.
4IgG against tetanus toxoid measured in absorbance at 450nm.
5
Glutathione peroxidase.
6
Measured in plasma.
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Table 2.5. Effect of treatment on Mean (±SEM) of study variables averaged over time
in lambs from 0-8 wks of age supplemented with maternal and direct vitamin E (EIE,
n=lO), only maternal (E/P, n=l 1), only direct (PIE, n=4), neither maternal nor direct
12
(PIP, n=5) '
Variables
6
Vitamin E (µg/ml)
IgG6 (mg/ml)
IgGTs,6 (OD4so)
Lysozyme3' 6 (µg/ml)
GSH-Px4'7 (nm of

PIP
1.47±0.67
12.47±1.41
0.36±0.08
0.35±0.05
0.86±0.13

PIE
1.28±0.11
9.75±2.17
0.27±0.08
0.43±0.15
0.76±0.09

EIE
EIP
2.43±0.47a 2.24±0.42
12.28±1.32 11.06±1.07
0.37±0.08
0.29±0.07
0.39±0.06
0.36±0.05
0.85±0.07
0.95±0.1

NADPH/min/mg of
protein)
107±7.4
100±7.6
99±4.2
97±3.5
Selenium7 (ng/ml)
Within a row, means with a superscript small letter differ (P :S 0.05).
1Supplemented with d-a-tocopherol (E, 30 IU d-a.-tocopherol /kg BW/2wks) or
~lacebo (P, emulsified base).
Variables were analyzed using PROC MIXED in SAS (SAS Inst. Inc, Cary, NC).
3
Treatment*Time interaction is present.
4
Glutathione peroxidase.
5
IgG against tetanus toxoid measured in absorbance at 450nm.
6Measured in serum.
7
Measured in plasma.
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Table 2.6. Effect of week on Mean (± SEM) of study variables measured over the length of the study in 0-8 wk old lambs1• 2
Variables
(Mean± SEM)

0

1

Vitamin E (µg/ml)

1.78 ±0.41

3.34 ± 0.39

lgG5 (mg/ml)

0

18.38 ± 1.23

13.9 ± 0.93

10.9 ± 0.58"

lgGT4,s (OD4so)

0

0.54 ± 0.06

0.45 ± 0.05"

GSH-Px3•
(nm ofNADPH/min/mg
of protein)

1.14 ± 0.05b

0.81 ± 0.08"

Selenium6 (ng/ml)

71.1±2.23

91.3± 2.78

6

2

Week oflife
3

4

6

8
1.17 ± 0.12

9.05±0.41"

9.65± 0.66"

7.33 ± 0.43

0.37 ± 0.05•

0.23 ± 0.03b

0.22 ± 0.03bc

0.14 ± 0.02°

0.7± 0.04"

0.74 ± 0.03"

0.79 ± 0.04"0

0.98 ± 0.07°

0.97 ± 0.06bc

87 ± 2.04 8

90.8 ± 2.37"b

97.7 ± 2.63b

122 ± 2.99

139 ± 3.57

1.92 ± 0.23

a-cwithin a row, means without a common superscript small letter differ (P ~ 0.001).
1
Lambs were divided in to four groups based on maternal and direct vitamin E (E/E, n=lO), only maternal (E/P, n=l 1), only direct
(PIE, n=4), neither maternal nor direct (PIP, n=5). Supplementation was in the form of d-a-tocopherol (E, 30 IU d-a-tocopherol /kg
BW/2wks) or placebo (P, emulsified base).
2
Variables were analyzed using PROC MIXED in SAS (SAS Inst. Inc, Cary, NC).
3
Glutathione peroxidase.
4
IgG against tetanus toxoid measured in absorbance at 450nm.
5
Measured in serum.
6
Measured in plasma.

Table 2.7. Effect of treatment on Mean (±SEM) of study variables averaged over time
in lambs during vaccination period supplemented with maternal and direct vitamin E
(E/E, n=lO), only maternal (EIP, n=l l), only direct (PIE, n=4), neither maternal nor
12
direct (PIP, n=5) '
Variables
36
Vitamin E • (µg/ml)
IgG6 (mg/ml)
Lysozyme6 (µg/ml)
GSH-Px4 ' 7 (nm of
NADPH!minlmg of
protein)
Selenium7 (ng/ml)

PIP

PIE

EIE

EIP

0.39±0.11
12.53±0.99
0.34±0.10
0.92±0.1

1.57±0.14
13.01±1
0.41±0.10
0.69±0.08

1.83±0.13
15.51±1.5
0.35±0.05
0.96±0.1

0.66±0.11
15.4±1.41
0.24±0.03
0.98±0.11

150±8

160±15.3

165±6.5

154±7.2

1

Supplemented with d-a-tocopherol (E, 30 IU d-a-tocopherol /kg BW/2wks) or
r,lacebo (P, emulsified base).
Variables were analyzed using PROC MIXED in SAS (SAS Inst. Inc, Cary, NC).
3
Treatment*time interaction is present (P '.S 0.001).
4
Glutathione peroxidase.
5
IgG against tetanus toxoid measured in absorbance at 450nm.
6
Measured in serum.
7
Measured in plasma.
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Table 2.8. Effect of week on Mean(± SEM) of study variables measured over the
length of the study in lambs during vaccination period I, 2,3
Variables
(Mean± SEM)
5

IgG (mg/ml)

0
12.19 ±0.81 "6

Weeks from primary vaccination
1
3
5
11.69 ± 0. 78° 16.05 ± 0.92 6
13.7 ± 0.7

7
19.6 ± 0.64

GSH-Px4' 6 (nm of
NADPH/min/mg of
protein)

1.18 ± 0.07°

1.12± 0.06"

1.01±0.05"

0.74± 0.06

0.55 ± 0.05

Selenium6 (ng/ml)

164±4.11°

156 ± 455•b

161 ± 5.19"

152 ± 3.66b

155 ± 3.95b

a- 6within

a row, means without a common superscript small letter differ (P < 0.001).
were divided in to four groups based on maternal and direct vitamin E (E/E,
n=IO), only maternal (E/P, n=l 1), only direct (PIE, n=4), neither maternal nor direct
(PIP, n=5). Supplementation was in the form of d-a.-tocopherol (E, 30 IU d-atocopherol /kg BW/2wks) or placebo (P, emulsified base).
2
Variables were analyzed using PROC MIXED in SAS (SAS Inst. Inc, Cary, NC).
3
Initial vaccination against Clostridium tetanus and Clostridium perfringens was at wk
0 and booster vaccination at wk 4 of the study.
4
Glutathione peroxidase.
5
Measured in serum.
6
Measured in plasma.
1Lambs
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Table 2.9. Effect of age on Mean(± SEM) of study variables averaged over time in
12
lambs during vaccination period ' ' 3
Variables

Age

Vitamin E (µg/ml)
IgG6 (mg/ml)

>12 wks
1.23 ± 0.09

< 12 wks
1.05 ± 0.07

14.58 ± 0.65

14.68 ± 0.54

Lysozyme6 (µg/ml)

0.36 ±0.02

0.29 ± 0.01

IgGTs,6 (OD4so)

0.53 ± 0.03

0.5 ± 0.03

GSH-Px4'7 (nm of
NADPH/min/mg of
protein)
Selenium7 (ng/ml)

0.87 ± 0.32

0.92 ± 0.37

168 ± 2.4

151±2.48a

6

Within a row, means with a superscript small letter differ (PS 0.05).
1
Lambs were divided in to four groups based on maternal and direct vitamin E (E/E,
n=lO), only maternal (E/P, n=l 1), only direct (PIE, n=4), neither maternal nor direct
(PIP, n=5). Supplementation was in the form of d-a-tocopherol (E, 30 IU d-atocopherol /kg BW/2wks) or placebo (P, emulsified base).
2
Variables were analyzed using PROC MIXED in SAS (SAS Inst. Inc, Cary, NC).
3
Initial vaccination against Clostridium tetanus and Clostridium perfringens was at wk
0 and booster vaccination at wk 4 of the study.
4
Glutathione peroxidase.
5
IgG against tetanus toxoid measured in absorbance at 450nm.
6
Measured in serum.
7
Measured in plasma.
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APPENDIX I

Standard Operating Procedure for the High Performance Liquid
Chromatography (HPLC)
Standard Operating Procedure from Journal of Chromatography by Arnaud et al.,
572: 1-2, pg.103-16.
The vitamins are sensitive to white light, oxidation, and to drying. Work under the
gold light, keep the extract under nitrogen, and resuspend the extract as soon as
possible. The following parameters describe a HPLC system used to separate and
quantitate 0-tocopherol in samples extracted from serum and feed samples.
1) Place 1 ml of serum in a 16 x 125 labeled test tube. Samples other than 1 ml (0.5,
etc.) can be run in the above manner, remember to take into account the
appropriate sample weight. Add a volume of 0.9% NaCl to equal 1 ml to all
samples that are less than 1 ml.
2) Add 1 ml of ethanol containing 0.01 % BHT and 0.1 % Ascorbic Acid.
3) Add 20uL of apocaroteneal internal standard.
4) Vortex for 5 minutes.
5) Add 1 ml HPLC grade hexane.
6) Vortex for 5 minutes.
7) Centrifuge at 3000rpm for 10 minutes.
8) Remove 0.5 ml of the top layer (hexane), dry using appropriate method.
9) Resuspend in 0.5 mL of mobile phase (70:20: 10: Acetonitrile, Methylene
Chloride, Methanol).
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1O) Transfer to HPLC vials and run on appropriate HPLC system.
-Mobile phase is 70:20:10 (v/v/v) acetonitrile: methylene chloride: methanol.
-Columns -guard column from Water's corp. Sentry guard column, Cl8, 3.5
µm
-analytical column: Water's corp. Symmetry C18, 3.5 µm, 4.6X75 mm
column.
-Flow rate: use a isocratic at a flow rate of 1.2 ml/min.
I

-Detector: Photo diode array or variable wavelength UV detector is used. The
wavelengths of interest are 292nm for alpha tocopherol, 265nm for
cholecalciferol, 325nm for retinol and 450nm for beta carotene.
-Injection volume: 50 µl
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APPENDIX II
Standard Operating Procedure for Lysoplate Assay
Lysozyme activity is measured by Lysoplate assay described according to Sotirov et
al., (2005) with some modifications. Analyze the samples in duplicates.
~

Preparation of culture media for Micrococcus luteus
Peptone ............................ 10 g
Yeast extract .................... 5 g
Sodium chloride .. ............ 5 g
Glucose ......................... . .. 1 g
Tryptone peptone ..... . .... 11 g
Agar .................................. 12 g
Distilled water .................. 1 L
Autoclave at 121 C for 15 minutes and pour into petridishes.

~

Preparation of standards: Prepare 1 mg/ml of the stock solution of Hen Egg
White Lysozyme(HEWL) (Sigma) in distilled water and store at -20° C in
aliquots.

1.

Streak M.luteus culture (ATCC 27141) on the prepared media and incubate
for 24 hr at 37°C.

2. Next, wash the bacterial culture with sodium phosphate buffer (Na2HPo 4 &
NaH2Po4, 0.7M pH-6.3) and mix it to form uniform suspension.
3. Adjust the optical density of the bacterial suspension to 1.8 and keep it in
water bath at 60° C
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4.

Prepare 2% agarose in sodium phosphate buffer and keep it in water bath to
attain 60°C temperature

5. Then, mix equal quantities of bacterial suspension and agarose in a container.
6. Mix it gently and pour 50 ml of agar+ bacterial suspension in the grid
petridishes.
7. Allow it to cool and keep it in refrigerator for 10 minutes.
8.

Remove the petridishes from refrigerator and cut wells using 5 mm well
cutter.

9.

Prepare lysozyme standards running from 3.125 to 0.048 µg/ml in serial
dilutions

10. Add 40 µl of standards and serum samples (directly without any dilution) or
colostrum samples ( 1: 10 dilut~on) into the wells in duplicates.
11. Incubate the loaded plates at 37° C for 24 hr.
12. After the incubation, the diameters of the clear, lytic zones formed around the
samples are compared with the lytic zones of HEWL standards.
13. Results are expressed as µg ofHEWL equivalent per ml.
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APPENDIX III
STAND ARD OPERATING PROCEDURE FOR IgG ENZYME LINKED
IMMUNOSORBANT ASSAY (ELISA)
Serum and Colostral IgG was measured using Sheep IgG kit (Bethyl labs,
E130-101). The kit included Purified sheep IgG, Rabbit antisheep IgG coating
antibody, Rabbit antisheep IgG HRP conjugated secondary antibody and TMB
susbtrate.
Preparation of reagents and solutions
1. Prepare coating buffer by dissolving contents of one carbonate bicarbonate capsule (Sigma-Aldrich; C-3041) in 100 ml distilled water to
give 0.05 M and 9.6 pH.
2. To prepare washing/sample/conjugate diluents/blocking buffers, dissolve 1
packet of Tris buffer (Sigma-Aldrich; T-9039) containing 50mM Tris,
O. l 4M NaCl, 0.05% Tween 20, pH 8.0 in 1 L of distilled water.
3. Mix equal components of the TMB (Trimethyl benzidine) substrate just
prior to use.
4. 2 M H 2S04 is used to terminate the reaction.
ELISA Procedure
1. Coat the wells ofNunc C bottom immunoplate 96 well plate (Fisher
Scientific, 12-565-267) with a dilution of 1µl of capture antibody to 100µ1
of coating buffer.
2. Incubate the plate for 60 minutes.
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10. Dilute HRP conjugated rabbit antisheep IgG in conjugate diluent to
1: 100,000 dilutions and add 1OOul/well.
11. Incubate for 60 minutes at room temperature and wash each well 5 times.
12. Mix equal volumes of TMB substrate just before adding to the wells and
transfer 1OOul/well.
13. Incubate for 15 minutes and 2M H2S04 to terminate the reaction.
14. Read the plate at 450nm wavelength using microplate reader.
15. Subtract the blank reading from each value.
16. Create a standard curve using Gen 5 software and calculate the
concentrations of the samples from the standard curve and the results are
reported in mg/ml.
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APPENDIX IV
STANDARD OPERATING PROCEDURE FOR IgG AGAINST TETANUS
TOXOID ENZYME LINKED IMMUNOSORBANT ASSAY (ELISA)
IgG against tetanus toxoid were measured according to the protocol described by
Rosskopf et al. (2005) with modifications.
Reagents needed:
Tetanus toxoid (150 Lf/ml) (Colorado serum company, 61415)
Rabbit antisheep IgG HRP conjugated antibody (Bethyl labs, A130-101P)
Wash buffer, blocking buffer, sample diluents and conjugate diluents: Phosphate
buffered saline+ 0.05% Tween 20
Carbonate bicarbonate buffer (Sigma-Aldrich; C-3041)
1.25 MH2S04
TMB susbtrate (Bethyl labs, E102)
ELISA procedure
1. Coat the wells of 96 well plate (Costar, 3590, flat bottom, high binding,
nonsterile) with 0.2 Lf/ml of Tetanus toxoid in 0.05M carbonate buffer, pH
9.6, lOOul/well.
2. Incubate overnight at 4° C and wash the plate with washing buffer 3 times
using plate washer (Biotek, ELX 405).
3. Add 250ul/well of blocking buffer and incubate for 60 minutes
4.

Cover the plate with plate sealer and shake at 150rpm, 37 ° C for lhr, followed
by washing step 3 times.
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5.

Dilute the serum samples to 1:2000 or 1: 1000 dilutions in sample diluent.

6. For colostrum samples, centrifuge at 24,400g at 4° C for 20 minutes. Remove
111

the fat layer from top and collect the sample from bottom and dilute to
1: 10,000 dilutions.
7. Add the samples in duplicates.
8. Cover the plate with plate sealer and shake at 150rpm, 37° C for lhr, followed
by washing step 3 times.
9. Dilute HRP conjugated rabbit antisheep IgG in conjugate diluent to 1:20,000
dilutions and add 1OOul/well.
10. Cover the plate with plate sealer and shake at 150rpm, 37° C for lhr, followed
by washing step 3 times.
11. Mix equal volumes of TMB substrate just before adding to the wells and
transfer 1OOul/well.
12. Incubate for 10 minutes and 1.25 M H2S04 to terminate the reaction.
13. Read the plate at 450nm wavelength using microplate reader.
14. Subtract the blank reading from each value.
15. Record the readings in absorbance units.
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